跳至主要内容
临床试验/NCT01512134
NCT01512134已完成不适用

Deep Brain Stimulation For Morbid, Treatment-Refractory, Obesity

Ali Rezai, MD2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
3
试验地点
2
主要终点
Percentage of excess weight loss

研究概览

简要总结

The purpose of this clinical study is to investigate the safety and efficacy of deep brain stimulation (DBS) as a treatment option for obesity.

详细描述

The purpose of this clinical study is to investigate the safety and efficacy of deep brain stimulation (DBS) as a treatment option in the management of severe, treatment refractory, morbid obesity.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
22 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • At least 24 months post Roux-en-Y gastric bypass surgery without evidence of a sustained improvement in BMI after gastric bypass surgery for at least 6 months.
  • Participant is willing to comply with all follow-up evaluations at the specified times
  • Participant is able to provide informed consent
  • Fluent in English

排除标准

  • Medical contraindications for general anesthesia, craniotomy, or DBS surgery
  • Evidence of neurological disorders, e.g., multiple sclerosis, Parkinson's disease and ischemic stroke, or severe brain atrophy or the presence of subdural hygromas or subdural hematomas.
  • Severe cardiovascular, pulmonary, renal, liver, hematological disease, severe coagulopathy, acute infectious process

结局指标

主要结局

Percentage of excess weight loss

时间窗: 2 years

The primary outcome measure at the conclusion of the study will be percent of excess weight loss (EWL).

次要结局

未报告次要终点

研究者

发起方
Ali Rezai, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ali Rezai, MD

Professor of Neurological Surgery

Ohio State University

研究点 (2)

Loading locations...

相似试验